Literature DB >> 3202127

Vestibular and audiologic functions in gentamicin-treated Menière's disease.

C Möller1, L M Odkvist, J Thell, B Larsby, D Hydén.   

Abstract

Fifteen patients with disabling Meniere's disease were treated with local intratympanic administration of gentamicin once daily. They had suffered from frequent attacks of vertigo and vomiting, the hearing in the affected ears was decreased permanently, and spontaneous nystagmus was observed. The number of treatment days ranged between 3 and 11. Follow-up time was 1 to 6 years. For evaluation of the treatment, audiologic and vestibular examinations were used, including the broad frequency-band rotatory test (0.4-4.5 Hz). Fourteen patients were free from vertigo after treatment. In 5 patients, there was an increased hearing loss, and in 10 it remained unchanged. Tinnitus and fullness sensations were diminished. After treatment, all ears were unresponsive to caloric stimulation. The clinical examination and rotatory testing in light with sinusoidal stimulation revealed good central compensation of the vestibular loss. However, with pseudorandomized oscillations in darkness, the broad frequency-band rotatory test quantified the loss of peripheral vestibular function and was able to detect the side of the lesion in eight of nine patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202127

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  6 in total

1.  Meniere's Syndrome.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method.

Authors:  Silvia Quaglieri; Omar Gatti; Elisabetta Rebecchi; Marco Manfrin; Carmine Tinelli; Eugenio Mira; Marco Benazzo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

3.  Low-dose intratympanic gentamicin treatment of Menière's disease.

Authors:  H Inoue; Y Uchi; K Nogami; T Uemura
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

4.  Intratympanic (IT) Therapies for Menière's Disease: Some Consensus Among the Confusion.

Authors:  Desi P Schoo; Grace X Tan; Matthew R Ehrenburg; Seth E Pross; Bryan K Ward; John P Carey
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-05-03

5.  Intratympanic Gentamicin for Intractable Ménière's Disease - A Review and Analysis of Audiovestibular Impact.

Authors:  Sertaç Yetişer
Journal:  Int Arch Otorhinolaryngol       Date:  2017-07-17

6.  Intratympanic gentamycine for Ménière's disease: is there a selective vestibulotoxic effect?

Authors:  András Molnár; Stefani Maihoub; Anita Gáborján; László Tamás; Ágnes Szirmai
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-30       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.